Register | Recovering MS Service

WELCOME

Merck in collaboration with UCLPartners invites you to the standalone promotional webinar: ‘MS, Rethinking Tomorrow’ for Academic Health Science Networks (AHSNs) and the MS clinical community – developed by Merck in collaboration with the AAC Cladribine Working Group, led by UCLPartners on behalf of the AHSN Network.

WEDNESDAY 30TH SEPTEMBER 2020, 5PM-6PM

The role of AAC-Designated Cladribine Oral Tablets in re-establishing MS services after COVID-19

In this promotional webinar we will explore the challenges in getting patients back on to DMT treatment during the COVID-19 pandemic and look at the role of cladribine tablets in appropriate patients. Each panelist will deliver a short presentation, followed by a facilitated Q&A on the issues discussed.

INSIGHTS AND PERSPECTIVES ON CLADRIBINE TABLETS PRE- AND DURING COVID-19 – LONDON PERSPECTIVE

Dr Heather Wilson, Consultant Neurologist, National Hospital for Neurology and Neurosurgery, London

INSIGHTS AND PERSPECTIVES ON CLADRIBINE TABLETS PRE- AND DURING COVID-19 – NOTTINGHAM UNIVERSITY HOSPITAL PERSPECTIVE

Dr Nikos Evangelou, Consultant Neurologist & Associate Clinical Professor, Nottingham University Hospital

INSIGHTS AND PERSPECTIVES ON CLADRIBINE TABLETS PRE- AND DURING COVID-19 – SOUTH WEST PERSPECTIVE

Professor Jeremy Hobart, Consultant Neurologist, Plymouth Hospitals NHS Trust

Chaired by Dr Charlie Davie, Consultant Neurologist, UCLPartners

This standalone promotional webinar is aimed at individuals within AHSNs who have an interest in MS services and the MS clinical community, including MS neurologists, MS nurses and pharmacists.

This promotional webinar has been initiated, organised and funded by Merck in collaboration with UCLPartners.

WEBCAST REGISTER

First Name^* Last Name^* Email Address^* Confirm Email^* Institution Name^* Country^* Mobile Number (Optional)

Emails don't match. Please enter the correct email.

Fields marked with (*) are mandatory.

By registering for the event I agree to the Merck Terms of Use and the Privacy Policy.^* By using this website, I consent to the Cookie Policy^*

The webinars and their content in this series are intended for HCPs in the UK and ROI only and individuals within AHSNs who have an interest in MS services.

This promotional webinar has been initiated, organised and funded by Merck in collaboration with UCLPartners.

Terms and Conditions:

Thank you for your interest in attending this Merck webinar. This webinar (our webinar) is owned and operated by Merck Serono Limited (“Merck”, “we”,“our”) and hosted on a third party platform run by Outlook (www.outlook.co.uk). These Terms of Use (together with the privacy and cookie policy referred to in it) tell you the terms on which you may take part to our webinar. By using our webinar, you confirm that you accept these terms of use and that you agree to abide by them. If you do not agree to these terms of use, please refrain from using our webinar.